Adobe Stock
Sun Pharma’s share price felt the heat today. After its Q1 FY26 results showed a steep profit decline, the share price tumbled nearly 4 per cent, trading at Rs 1,639 on the BSE. But scratch beneath the surface and you’ll find a company still built on strong fundamentals, global reach and steady returns that could appeal to long-term investors.
Why has Sun Pharma's share price declined?
- Earnings dip: Net profit fell nearly 20 per cent YoY due to one-time charges, though operating profit grew double digits.
- Global jitters: Broader pharma weakness and trade tariff worries added to the selloff.
Q1 FY26 results snapshot
| Metric | Q1 FY26 | Q1 FY25 | YoY change |
|---|---|---|---|
| Revenue (Rs crore) | 12,710 | 11,998 | 5.9 per cent |
| Operating profit (Rs crore) | 3,991 | 3,424 | 16.6 per cent |
| Net profit (Rs crore) | 2,278 | 2,836 | - 19.7 per cent |
| EBITDA margin (%) | 30.4 | 28.6 | 180 bps |
Why it matters for investors
Yes, the Q1 headline numbers rattled the market. However, most of the profit drop was due to exceptional items, such as asset impairments and legal charges. Stripped of these, the operational performance looked healthier. The stock’s premium valuation may keep near-term upside capped, but strong return ratios and steady specialty revenue give it long-term heft.
About the company
Sun Pharmaceutical Industries is India’s biggest pharma player and a global leader in specialty generics. With products spanning over 100 countries and a strong presence in dermatology, oncology and chronic therapies, it blends scale with innovation.
Why you shouldn’t be affected by Sun Pharma’s share price decline
Investing isn’t just about reacting to headlines. It’s about digging deeper, spotting quality and staying patient. Tools like Value Research Stock Advisor can help you cut through the clutter, assess fundamentals, and make smarter, more informed decisions.
Disclaimer: This article was crafted with the aid of artificial intelligence and meticulously reviewed and edited by our human experts to ensure accuracy and provide valuable insights. It's intended for informational purposes only. We encourage you to conduct your own thorough research before making any investment decisions.
Ask Value Research 
New episodes every Friday 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
